山东大学学报 (医学版) ›› 2018, Vol. 56 ›› Issue (3): 79-84.doi: 10.6040/j.issn.1671-7554.0.2017.097
• • 上一篇
张秀玲,张磊,刘丹,梁江久
ZHANG Xiuling, ZHANG Lei, LIU Dan, LIANG Jiangjiu
摘要: 目的 初步探讨山东汉族人群ApoE基因 112位点和158位点基因多态性与房颤发生的相关性。 方法 经临床诊断为房颤患者92例(房颤组),同期体检者93例(对照组),收集所有患者一般临床资料,并收集全血,提取全血DNA,采用芯片法检测其ApoE基因112位点和158位点基因多态性。计数资料之间的比较采用χ2检验,计数小于5时选用Fisher精确检验法;计量资料比较均采用t检验;房颤发生相关多因素分析采用二元Logistic回归分析。 结果 房颤组与对照组相比,ApoE基因112位点基因型频率、等位基因频率差异有统计学意义(P<0.05);158位点基因型频率、等位基因频率差异无统计学意义(P>0.05);载脂蛋白E表型差异有统计学意义(P<0.05),ApoE4型者房颤发生率高。 结论 山东汉族人群ApoE基因多态性与房颤发生具有一定的相关性,ApoE4是房颤的敏感表型,携带ApoE4型者罹患房颤的可能性更大。
中图分类号:
[1] Ruiz JR, Labayen I, Ortega FB, et al. Birth weight and blood lipid levels in Spanish adolescents: influence of selected APOE, APOC3 and PPARgamma2 gene polymorphisms. The AVENA Study[J]. BMC Med Genet, 2008, 9(10): 98. [2] Torres-Perez E, Ledesma M, Garcia-Sobreviela MP, et al. Apolipoprotein E4 association with metabolic syndrome depends on body fatness[J]. Atherosclerosis, 2016, 245: 35-42. [3] Cheema AN, Bhatti A, Wang X, et al. APOE gene polymorphism and risk of coronary stenosis in Pakistani population[J]. Biomed Res Int, 2015: 1-5. [4] Karahan Z, Ugurlu M, Uçaman B, et al. Relation between Apolipoprotein E gene polymorphism and severity of coronary artery disease in acute myocardial infarction[J]. Cardiol Res Pract, 2015: 1-4. [5] Abd El-Aziz TA, Mohamed RH. LDLR, ApoB and ApoE genes polymorphisms and classical risk factors in premature coronary artery disease[J]. Gene, 2016, 590(2): 263-269. [6] Raygani AV, Rahimi Z, Kharazi H, et al. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease[J]. Neurosci Lett, 2006, 408(1): 68-72. [7] Raygani AV, Zahrai M, Raygani AV, et al. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran[J]. Neurosci Lett, 2005, 375(1): 1-6. [8] Das S, Kaul S, Jyothy A, et al. Association of APOE(E2, E3 and E4)gene variants and lipid levels in ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian population[J]. Neurosci Lett, 2016, 628: 136-141. [9] Watanabe H, Tanabe N, Yagihara N, et al. Association between lipid profile and risk of atrial fibrillation[J]. Circ J, 2011, 75(12): 2767-2774. [10] Alonso A, Yin X, Roetker NS, et al. Blood lipids and the incidence of atrial fibrillation: the multi-Ethnic study of atherosclerosis and the framingham heart study[J]. J Am Heart Assoc, 2014, 3(5): 1211-1221. [11] Wong CX, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions[J]. Eur Heart J, 2017, 38(17): 1294-1306. [12] Liu F, Li Y, Xu Y. Weight loss to prevent atrial fibrillation: The role of epicardial adipose tissue[J]. Int J Cardiol, 2016, 204: 124-129. [13] 魏涛涛, 郭雪娅. 心房颤动新型危险因素的研究进展[J]. 中国循环杂志, 2016, 31(7): 720-722. [14] Lee JJ, Yin X, Hoffmann U, et al. Relation of pericardial fat, intrathoracic fat, and abdominal visceral fat with incident atrial fibrillation(from the Framingham Heart Study)[J]. Am J Cardiol, 2016, 118(10): 1486-1492. [15] Garcia-Sayan E, Patel M, Wassouf M, et al. Derivation and validation of E/e' ratio as a parameter in the evaluation of left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation[J]. Int J Cardiovasc Imaging, 2016, 32(9): 1349-1356. [16] Nalliah CJ, Sanders P, Kottkamp H, et al. The role of obesity in atrial fibrillation[J]. Eur Heart J, 2016, 37(20): 1565-1572. [17] Jofre-Monseny L, Minihane AM, Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk[J]. Mol Nutr Food Res, 2008, 52(1): 131-145. [18] Huebbe P, Lodge JK, Rimbach G. Implications of apolipoprotein E genotype on inflammation and vitamin E status[J]. Mol Nutr Food Res, 2010, 54(5): 623-630. [19] 吴丹丹, 陈瑜, 张腾. 房颤发病机制研究新进展[J]. 中西医结合心脑血管病杂志, 2016, 4(12): 1342-1346. [20] Hu YF, Chen YJ, Lin YJ, et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol, 2015, 12(4): 230-243. [21] Bas HA, Aksoy F, Icli A, et al. The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction[J]. Scand J Clin Lab Invest, 2017, 77(2): 77-82. [22] Harada M, Van Wagoner DR, Nattel S. Role of inflammation in atrial fibrillation pathophysiology and management[J]. Circ J, 2015, 79(3): 495-502. [23] Rollo J, Knight S, May HT, et al. Incidence of dementia in relation to genetic variants at PITX2, ZFHX3, and ApoE epsilon4 in atrial fibrillation patients[J]. Pacing Clin Electrophysiol, 2015, 38(2): 171-172. [24] Velagaleti RS, Massaro J, Vasan RS, et al. Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study[J]. Circulation, 2009, 120(23): 2345-2351. [25] Rye KA, Barter PJ. Cardioprotective functions of HDLs[J]. J Lipid Res, 2014, 55(2): 168-179. [26] Guo Y, Lip GYH, Apostolakis S. Inflammation in atrial fibrillation[J]. J Am Coll Cardiol, 2012, 60(22): 2263-2270. [27] Yang KC, Dudley SC. Oxidative stress and atrial fibrillation: finding a missing piece to the puzzle[J]. Circulation, 2013, 128(16): 1724-1726. [28] Eichner JE, Dunn ST, Perveen G, et al. 2002. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review[J]. Am J Epidemiol, 2002, 155(6): 487-495. [29] Lee JJ, Yin X, Hoffmann U, et al. Relation of pericardial fat, intrathoracic fat, and abdominal visceral fat with incident AF(from the Framingham Heart Study)[J]. Am J Cardiol, 2016, 118(10): 1486-1492. [30] Luscher TF. Atrial fibrillation: novel risk factors, mechanisms and ablation techniques[J]. Eur Heart J, 2016, 37(20): 1553-1555. [31] Scridon A, Dobreanu D, Chevalier P, et al. Inflammation, a link between obesity and atrial fibrillation[J]. Inflamm Res, 2015, 64(6): 383-393. [32] Zhu Y, Nwabuisi-Heath E, Dumanis SB, et al. APOE genotype alters glial activation and loss of synaptic markers in mice[J]. Glia, 2012, 60(4): 559-569. |
[1] | 徐宁宇 王磊 郝恩魁 苏国海. STEMI患者急诊PCI前口服阿托伐他汀对炎症介质及左心室功能的影响[J]. 山东大学学报(医学版), 2209, 47(6): 69-72. |
[2] | 葛丽娟 金瑞峰 王纪文 许新升 李癊. 多药耐药基因1 C1236T多态性与癫痫患者对药物反应性的相关性[J]. 山东大学学报(医学版), 2209, 47(6): 99-102. |
[3] | 郝跃伟 刘雪平 赵婷婷 郑敏 王一兵. 环氧化酶2基因多态性与动脉粥样硬化缺血性脑卒中的相关性[J]. 山东大学学报(医学版), 2209, 47(6): 95-98. |
[4] | 张凤,吴哲,徐俊,刘玉兰. 6例非酒精性脂肪性肝病小鼠肠道B细胞的变化[J]. 山东大学学报 (医学版), 2022, 60(9): 67-73. |
[5] | 吴虹,张正铎,唐延金,祁少俊,高希宝. 5-甲基四氢叶酸对大鼠动脉粥样硬化的潜在干预作用[J]. 山东大学学报 (医学版), 2022, 60(8): 6-13. |
[6] | 张秉芬,周胜红,王哲. 延龄草皂苷通过抑制TGF-β/Smad3与Wnt/β-catenin信号通路改善大鼠肺纤维化[J]. 山东大学学报 (医学版), 2022, 60(8): 23-29. |
[7] | 李锐,石存现,于翠翠. 右美托咪定对30例体外循环患者肠道屏障损伤的影响[J]. 山东大学学报 (医学版), 2022, 60(7): 83-88. |
[8] | 刘岩,张曼,姜朝阳,卞姝,杜艾家,陈鹤. LncRNA-HOTAIR调控H3K27me3影响巨噬细胞迁移的机制[J]. 山东大学学报 (医学版), 2022, 60(6): 1-9. |
[9] | 邬雨洁,张明泉,纪永利,赵璐,王越,陈沙沙. 寒痉汤及其拆方对寒凝证高血压大鼠血清炎症因子、血管内皮功能及纤维化的影响[J]. 山东大学学报 (医学版), 2022, 60(6): 10-18. |
[10] | 张秀芳,李沛铮,张博涵,孙丛丛,刘艺鸣. 生长分化因子15在LPS诱导的帕金森病模型中的保护作用及机制[J]. 山东大学学报 (医学版), 2022, 60(5): 1-7. |
[11] | 刘敏,张玉超,马小莉,刘昕宇,孙露,左丹,刘元涛. 孤核受体NR4A1在H2O2诱导小鼠肾脏足细胞损伤中的作用[J]. 山东大学学报 (医学版), 2022, 60(5): 16-21. |
[12] | 虎娜,孙苗,邢莎莎,许丹霞,海小明,马玲,杨丽,勉昱琛,何瑞,陈冬梅,马会明. 月见草油抵抗多囊卵巢综合征大鼠卵巢氧化应激[J]. 山东大学学报 (医学版), 2022, 60(5): 22-30. |
[13] | 孙继业,王紫欧,孙晓伟,李洪涛. 中药熏蒸联合体外冲击波对72例髋关节撞击综合征临床疗效、血清炎症因子水平的影响[J]. 山东大学学报 (医学版), 2022, 60(4): 76-81. |
[14] | 宋洛卿,周国钰,叶翔,卢梅,赵新静. 脑淀粉样血管病相关炎症长期误诊1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(4): 119-122. |
[15] | 黄辉宁,杜娟娟,孙燚,侯应龙,高梅. 硫化氢通过glutaredoxin-1调节氧化应激减轻急性阻塞性睡眠呼吸暂停诱发房颤的机制[J]. 山东大学学报 (医学版), 2022, 60(1): 1-5. |
|